Overview New advancements in connectivity, artificial intelligence, and image storage and processing have led to the development of new tools for healthcare providers, including software…
On January 6, 2025, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) issued its final version of the “Guideline…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
On December 27, 2024, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued a Notice of Proposed Rulemaking (NPRM)…
The National Institutes of Health (NIH) invites nominations for the annual Matilda White Riley Behavioral and Social Sciences Honors, a celebration of Dr. Matilda White…
Are you ready to elevate your research skills and make a lasting impact in health-related behavioral interventions? Applications are now open for the 2025 National…
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
“CITI Program Funding Finds” is our monthly blog series which highlights opportunities relevant to research grants, funding, programs open to new applicants, and more. Follow…
Introduction The FDA’s draft guidance Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics proposes an accelerated approval pathway, which would expedite access to…
Season 1 – Episode 28 – 3Rs Technologies in Animal Research Discusses the 3Rs of animal research, teaching, and testing (replacement, reduction, and refinement), including…
The Office for Human Research Protections (OHRP) has recently made three impactful webinar recordings available, offering invaluable insights into some of the most pressing topics…
The FDA recently issued draft guidance titled “FDA Guidance on Protocol Deviations,” which provides critical insights into managing protocol deviations during clinical trials. The document…
